clinical_trials
A novel candidate biomarker for detecting premalignant and early ovarian cancer
Confidence95·multiple reportsImportance97NP-EVT-20261110-5958653
Nature Medicine, Published online: 10 November 2026; doi:10.1038/s41591-026-04755-2 New data suggest that the long noncoding RNA known as Tu-Stroma represents a promising new circulating biomarker for the detection of ovarian cancer at premalignant and early stages, for which sensitive screening methods currently are lacking.
Read the original at the primary source
A novel candidate biomarker for detecting premalignant and early ovarian cancer
Dmitriy Zamarin · 11/10/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —